The News Feed

Diabetes

Prevalence of DR Rises, While Dilated Exam Rates Decreased

Screenings went down in all populations except non-metropolitan statistical area communities, showing that a greater understanding of health disparities in these areas is needed.
January 14, 2025

Survey Explores Frustrations of DME Patients

Frequent clinic visits, insufficient one-on-one counseling from their doctors and worries of being a burden to caregivers were among the concerns.
January 9, 2025

Popular Type 2 Diabetes Drug Could Possibly Lower Glaucoma Incidence

Meta-analysis found GLP-1 receptor agonist use in these patients was associated with a 29% decrease in risk, though results were not uniform across all studies.
January 6, 2025

Patients on GLP-1 Agonists, Fenofibrates Have Lower Risk of DME

Study also shows those on calcium channel blockers experienced an increased risk against the condition.
December 10, 2024

Empagliflozin Could Potentially Lower DR Progression

Initiation of this SGLT2 inhibitor was associated with reduced development of the nonproliferative form.
December 9, 2024

Meta-Analysis Finds Weak Association Between Periodontitis and DR

Many studies suggest a relationship but the quality of the evidence is low, researchers determined.
December 3, 2024

Living in the Southern US, Poorer Health Status Linked to Likelihood of Diabetic Retinopathy

Study reveals how factors such as healthcare access, economic stability and geography contribute to higher rates of the disease, emphasizing the need for focused health policies and interventions.
November 21, 2024

Semaglutide Doesn’t Increase NAION Risk in General Population, Study Shows

This was found to be true at one, two and three years of follow-up in patients taking the GLP-1 medication for type 2 diabetes, obesity or both.
November 6, 2024

DR Severity Associated with Number of Intraretinal Microvascular Abnormalities

Observation of these findings may serve as a surrogate of disease progression.
November 4, 2024

Vitreous Hemorrhage Benefits from Earlier Vitrectomy

Significantly better visual outcomes were reported in eyes that underwent PPV within six weeks of the incident.
October 31, 2024